Hoechst Pakistan (KAR:HPL) Beneish M-Score: -2.83 (As of Jun. 26, 2026)


KAR:HPL Hoechst Pakistan Ltd KAR:HPL
86 GF Score
Price ₨4,015.00
GF Value ₨3,252.20
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Hoechst Pakistan Beneish M-Score?

Hoechst Pakistan KAR:HPL +0.08% 86 Beneish M-Score is -2.83 as of Jun. 26, 2026. GuruFocus rates KAR:HPL with a GF Score™ of 86/100 and a GF Value™ of ₨3,252.20 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 911 Drug Manufacturers companies, Hoechst Pakistan ranks better than 76.95% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.83 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Hoechst Pakistan's Beneish M-Score or its related term are showing as below:

KAR:HPL' s Beneish M-Score Range Over the Past 10 Years
Min: -3.44   Med: -2.34   Max: -0.96
Current: -2.83

During the past 13 years, the highest Beneish M-Score of Hoechst Pakistan was -0.96. The lowest was -3.44. And the median was -2.34.


Hoechst Pakistan Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Hoechst Pakistan's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hoechst Pakistan Beneish M-Score Chart

Hoechst Pakistan Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.73 -2.21 -3.38 -1.29 -2.32

Hoechst Pakistan Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -2.06 -1.95 -2.32 -2.83

KAR:HPL vs LLY, JNJ, ABBV: Beneish M-Score Comparison

For the Drug Manufacturers - General subindustry, Hoechst Pakistan's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoechst Pakistan Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Hoechst Pakistan's Beneish M-Score falls into.


KAR:HPL
86GF Score
Hoechst Pakistan Ltd KAR:HPL
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hoechst Pakistan Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Hoechst Pakistan for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.727+0.528 * 0.9071+0.404 * 1.1336+0.892 * 1.1087+0.115 * 1.0741
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.998+4.679 * -0.048898-0.327 * 0.9436
=-2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₨841 Mil.
Revenue was 7699.476 + 6386.399 + 8284.284 + 8711.238 = ₨31,081 Mil.
Gross Profit was 2967.677 + 2646.531 + 3047.371 + 2933.484 = ₨11,595 Mil.
Total Current Assets was ₨10,728 Mil.
Total Assets was ₨15,190 Mil.
Property, Plant and Equipment(Net PPE) was ₨2,886 Mil.
Depreciation, Depletion and Amortization(DDA) was ₨378 Mil.
Selling, General, & Admin. Expense(SGA) was ₨2,760 Mil.
Total Current Liabilities was ₨5,904 Mil.
Long-Term Debt & Capital Lease Obligation was ₨382 Mil.
Net Income was 710.899 + 680.458 + 875.68 + 790.338 = ₨3,057 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₨0 Mil.
Cash Flow from Operations was 2209.094 + -121.31 + 10.738 + 1701.599 = ₨3,800 Mil.
Total Receivables was ₨1,043 Mil.
Revenue was 7573.493 + 6231.068 + 7185.969 + 7043.482 = ₨28,034 Mil.
Gross Profit was 2685.809 + 2134.971 + 2507.795 + 2158.234 = ₨9,487 Mil.
Total Current Assets was ₨9,693 Mil.
Total Assets was ₨13,123 Mil.
Property, Plant and Equipment(Net PPE) was ₨2,229 Mil.
Depreciation, Depletion and Amortization(DDA) was ₨317 Mil.
Selling, General, & Admin. Expense(SGA) was ₨2,494 Mil.
Total Current Liabilities was ₨5,544 Mil.
Long-Term Debt & Capital Lease Obligation was ₨210 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(840.604 / 31081.397) / (1042.96 / 28034.012)
=0.027045 / 0.037203
=0.727

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9486.809 / 28034.012) / (11595.063 / 31081.397)
=0.338404 / 0.373055
=0.9071

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (10727.749 + 2885.64) / 15189.794) / (1 - (9692.815 + 2228.604) / 13122.758)
=0.103781 / 0.091546
=1.1336

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=31081.397 / 28034.012
=1.1087

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(316.961 / (316.961 + 2228.604)) / (378.389 / (378.389 + 2885.64))
=0.124515 / 0.115927
=1.0741

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2760.128 / 31081.397) / (2494.439 / 28034.012)
=0.088803 / 0.088979
=0.998

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((382.074 + 5903.542) / 15189.794) / ((210.488 + 5544.08) / 13122.758)
=0.413805 / 0.438518
=0.9436

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3057.375 - 0 - 3800.121) / 15189.794
=-0.048898

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Hoechst Pakistan has a M-score of -2.83 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.83 mean?
Hoechst Pakistan (KAR:HPL) has a Beneish M-Score of -2.83 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Hoechst Pakistan and its competitors. According to the industry distribution chart, Hoechst Pakistan ranks #210 out of 911 companies in the Drug Manufacturers industry, placing it in the top 23.1%.
Is Hoechst Pakistan's Beneish M-Score too high?
Hoechst Pakistan's current Beneish M-Score is -2.83. Based on the distribution chart, Hoechst Pakistan ranks #210 out of 911 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hoechst Pakistan has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoechst Pakistan's Beneish M-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Hoechst Pakistan ranks #210 out of 911 companies for Beneish M-Score. This places Hoechst Pakistan in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Hoechst Pakistan and its competitors. Hoechst Pakistan's current Beneish M-Score is -2.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoechst Pakistan stock overvalued right now?
Based on GuruFocus' analysis, Hoechst Pakistan (KAR:HPL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨3,252.20, compared to a current price of ₨4,015.00 — trading 23.5% above its estimated fair value. The current Beneish M-Score is -2.83. Hoechst Pakistan's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Hoechst Pakistan (KAR:HPL), the current Beneish M-Score is -2.83 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hoechst Pakistan (KAR:HPL) Overvalued in 2026?

Based on GuruFocus' analysis, Hoechst Pakistan stock appears to be overvalued. The current stock price of ₨4,015.00 is trading 23.5% above its estimated GF Value™ of ₨3,252.20. GuruFocus considers Hoechst Pakistan to be Modestly Overvalued.

Key valuation signals for KAR:HPL:

  • Beneish M-Score: -2.83
  • GF Value™: ₨3,252.20 vs. price of ₨4,015.00 (23.5% above fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the KAR:HPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hoechst Pakistan Business Description

Address Plot 23, Sector 22, Korangi Industrial Area, Karachi, PAK, 74900
Hoechst Pakistan Ltd is a healthcare company of Pakistan, focused on patient needs and engaged in the manufacturing, promotion, and sale of pharmaceutical and vaccines. The company engages in the manufacturing, selling and trading of pharmaceutical and related products.
86GF Score

Get the complete analysis for KAR:HPL

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨4,015.00
Price
₨3,252.20
GF Value